Multiple Sclerosis Therapies Market Outlook
Multiple sclerosis (MS) therapies involve the administration of injectable, infused and oral medicines, antidepressants, muscle relaxants, and physical therapy. They aid in slowing the progression of the disease and managing associated symptoms.
The global multiple sclerosis therapies market size reached US$ 24.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32.3 Billion by 2027, exhibiting a growth rate (CAGR) of 4.61% during 2022-2027.
Apart from this, they also help in controlling the heart rate and blood pressure and minimizing the frequency of relapses among patients.
Request for a Free PDF sample report: https://www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsample
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Multiple Sclerosis Therapies Market Trends:
At present, the increasing prevalence of relapsing-remitting and secondary progressive MS across the globe represents one of the primary factors driving the market. Besides this, governing agencies of numerous countries are launching campaigns to generate awareness about the available treatments.
This, along with the technological advancements, such as the introduction of innovative immunomodulators, monoclonal bodies, interferons, and immunosuppressants for the effective treatment of MS, is creating a favorable market outlook. Other factors, including considerable improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to stimulate the growth of the market.
Buy This Report Now: https://www.imarcgroup.com/checkout?id=2571&method=1
Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.
Competitive Landscape with Key Players:
The report has also analysed the competitive landscape of the market with some of the key players.
- Abbvie Inc.
- Bayer Aktiengesellschaft
- Biogen Inc.
- Bristol-Myers Squibb Company
- Hoffmann-La Roche AG (Roche Holding AG)
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Novartis AG
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
Key Market Segmentation:
The report has categorized the market based on drug, drug type, route of administration and distribution channel.
Breakup by Drug:
- Immunomodulators
- Copaxone
- Avonex/Plegridy
- Gilneya
- Tysabri
- Betaseron/Extavia
- Tecifidera
- Rebif
- Ampyra
- Immunosuppressants
- Aubagio
- Lemtrada
- Ocrelizumab
- Zinbryta
Breakup by Drug Type:
- Biologic Drugs
- Small Molecule Drugs
Breakup by Route of Administration:
- Oral
- Injectable
- Intravenous
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2571&flag=C
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
https://think-how.com/carrageenan-market-size-trends-growth-and-forecast-2022-2027/
https://myinvestmentplaybook.com/carrageenan-market-share-growth-scope-and-forecast-2022-2027/
https://smallpetanimals.com/carrageenan-market-trends-demand-analysis-and-forecast-2022-2027/
https://think-how.com/medical-tapes-and-bandages-market-size-trends-growth-and-forecast-2022-2027/
https://myinvestmentplaybook.com/medical-tapes-and-bandages-market-share-growth-scope-and-forecast-2022-2027/
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800
0
